SRPTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Sarepta Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$17.73+0.63 (+3.68%)
Close on Oct 19, 2026
- Market cap
- $1.87B
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Sarepta Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Aug 5, 2026 | Aug 5, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 5, 2026 | SEC EDGAR |
| Current report | 8-K | Jul 23, 2026 | Jul 27, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 4, 2026 | Jun 4, 2026 | SEC EDGAR |
| Current report | 8-K | May 6, 2026 | May 6, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 6, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 4, 2026 | Apr 24, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 2, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Feb 25, 2026 | Feb 25, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 12, 2026 | Jan 12, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 18, 2025 | Dec 19, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 10, 2025 | Dec 11, 2025 | SEC EDGAR |
| Current report | 8-K | Dec 7, 2025 | Dec 8, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 6, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 3, 2025 | Nov 3, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 28, 2025 | Aug 29, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 18, 2025 | Aug 21, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 13, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 6, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 21, 2025 | Jul 21, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 14, 2025 | Jul 16, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 5, 2025 | Jun 6, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 6, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 5, 2025 | Apr 24, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Feb 28, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 26, 2025 | Feb 26, 2025 | SEC EDGAR |
| Current report | 8-K | Feb 13, 2025 | Feb 14, 2025 | SEC EDGAR |
| Current report | 8-K | Jan 13, 2025 | Jan 13, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 24, 2024 | Nov 26, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Sep 12, 2024 | Sep 16, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 7, 2024 | SEC EDGAR |
| Current report | 8-K | Jun 6, 2024 | Jun 7, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2024 | May 1, 2024 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 6, 2024 | Apr 24, 2024 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2023 | Feb 28, 2024 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2024 | Jan 8, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2023 | Nov 1, 2023 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2023 | Aug 2, 2023 | SEC EDGAR |